Search clinical trials for: rollover protocol

Total 8932 results

Novartis Pharmaceuticals

Active, not recruiting

CINC424A2X01B Rollover Protocol

Acute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Thalassemia | Graft Versus Host Disease

China, Germany, Italy, Australia, Thailand, Greece, Spain, Canada, Bulgaria, Hungary, Israel, South Africa, France, Japan, India, Sweden, Poland, Belgium, Chile, Mexico, Turkey (Türkiye), South Korea, Russia, Lebanon, Portugal
Eli Lilly and Company

Available

Master Rollover Protocol for Continued Safety Assessment of Study Drug

Cancer

United States
Context Therapeutics Inc.

Withdrawn

A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer

Breast Cancer

United States
AstraZeneca

Completed

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

Melanoma | Neoplasms | Renal Cell Carcinoma | Prostatic Neoplasms | Colorectal Neoplasms | Patients Who Have/Have Had Melanoma and Other Tumors

United States, United Kingdom
Sumitomo Pharma America, Inc.

Completed

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Oncology

United States, Taiwan, Japan, France

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe